These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20508384)

  • 21. Two cases of pseudohypoparathyroidism in adolescent boys.
    Kabícek P; Kutílek S; Bayer M; Stĕpán JJ
    Acta Univ Carol Med (Praha); 1994; 40(1-4):53-6. PubMed ID: 9355673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
    Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
    J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib.
    Silve C; Santora A; Breslau N; Moses A; Spiegel A
    J Clin Endocrinol Metab; 1986 Apr; 62(4):640-4. PubMed ID: 3005354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.
    Breslau NA; Notman DD; Canterbury JM; Moses AM
    Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudohypoparathyroidism type I and vitamin D therapy].
    Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
    Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
    Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
    J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoparathyroidism and pseudohypoparathyroidism.
    Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
    Kawata T; Imanishi Y; Kobayashi K; Onoda N; Takemoto Y; Tahara H; Okuno S; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5774-8. PubMed ID: 16046589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
    Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.
    Kruse K; Kracht U
    Eur J Pediatr; 1987 Jul; 146(4):373-7. PubMed ID: 2820733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
    Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
    Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful off-label use of cinacalcet HCl after standard therapy failure in a young man with pseudohypoparathyroidism Type 1b and vitamin D intoxication sequelae.
    Koch M; Kohnle M
    Clin Nephrol; 2008 Nov; 70(5):439-44. PubMed ID: 19000547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus.
    Linglart A; Bastepe M; Jüppner H
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):822-31. PubMed ID: 17651445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of pseudohypoparathyroidism. Involvement of progressively increasing serum parathyroid hormone concentrations, increased 1,25-dihydroxyvitamin D concentrations, and 'migratory' subcutaneous calcifications.
    Tsang RC; Venkataraman P; Ho M; Steichen JJ; Whitsett J; Greer F
    Am J Dis Child; 1984 Jul; 138(7):654-8. PubMed ID: 6328970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders.
    Okazaki R; Matsumoto T; Furukawa Y; Fujimoto Y; Niimi H; Seino Y; Fujita T; Nagataki S; Ogata E
    Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.